Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors’ knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-a 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.
BrownA.D., Lopez-TerradaD., DennyK.A.: Promoters containing ATF-binding sites are deregulated in cells that express the EWS/ATF-1 oncogene.Oncogene, 10: 1749–1756, 1995.
3.
ChungE.B., EnzingerF.M.: Malignant melanoma of soft parts.A reassessment of clear cell sarcoma. Am. J. Surg. Pathol., 7: 405–413, 1983.
4.
EckardtJ.J., PritchardD.J., SouleE.H.: Clear cell sarcoma.A clinicopathological study of 27 cases. Cancer, 52: 1482–1488, 1983.
5.
EckforsT.O., KujariH., IsomakiM.: Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) in the duodenum: the first visceral case.Histopathology, 22: 255–259, 1993.
EnzingerF.M.: Clear cell sarcoma of tendons and aponeuroses.An analysis of 21 cases. Cancer, 18: 1163–1174, 1965.
8.
EnzingerF.M., WeissS.W.: Clear cell sarcoma (malignant melanoma of soft parts). In: Soft Tissue Tumors, 3rd edition, pp. 913–919, Mosby, St. Louis, 1995.
9.
FujimuraY., OhnoT., SiddiqueH., LeeL., RaoV.N., ReddyE.S.: The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.Oncogene, 12: 159–167, 1996.
10.
HadjiyannakisM.J., PapadimitriouC.A., ElemenoglouJ.: Clear cell sarcoma (malignant melanoma of soft parts).Presentation of two additional cases. Eur. J. Surg. Oncol., 19: 206–208, 1993.
11.
HicksM.J., SaldivarV.A., ChintagumpalaM.M., HorowitzM.E., CooleyL.D., BarrishJ.P.: Malignant melanoma of soft parts involving the head and neck region: review of the literature and case report.Ultrastruct. Pathol., 19: 395–400, 1995.
12.
LiaoS.K., PerngY.P., LeeL.A., ChangK.S., LaiG.M., WongE., HoY.S.: Newly established MST-1 tumor cell line and tumor-infiltrating lymphocyte culture from a patient with soft tissue melanoma (clear cell sarcoma) and their potential application to patient immunotherapy.Eur. J. Cancer, 32A: 346–356, 1996.
13.
MartinelliG., CavalliF.: Alpha-interferon alone or in combination with chemotherapy in the treatment of malignant melanoma, renal cell carcinoma and other solid tumors. In: Interferons in Oncology - Current Status and Future Directions, SmythJ.F. (Ed.), pp. 33–38, European School of Oncology Monographs, Springer Verlag, Berlin-Heidelberg, 1987.
14.
NedoszytkoB., MrozekK., RoszkiewiczA., KopaczA., SwierblewskiM., LimonJ.: Clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) diagnosed initially as malignant melanoma.Cancer Genet. Cytogenet., 91: 37–39, 1996.
15.
PavlidisN.A., FisherC., WiltshawE.: Clear cell sarcoma of tendons and aponeuroses: a clinicopathological study.Cancer, 54: 1412–1417, 1984.
16.
RadstoneD.J., RevellP.A., MantellB.S.: Clear cell sarcoma of tendons and aponeuroses treated with bleomycin and vincristine.Br. J. Radiol., 52: 238–241, 1979.
17.
SantoroA., TurszT., MouridsenH., VerweijJ., StewardW., SomersR., BuesaJ., CasaliP., SpoonerD., RankinE.: Doxorubicin versus CyVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the EORTC Soft Tissue and Bone Sarcoma Group.J. Clin. Oncol., 13: 1537–1545, 1995.
18.
SaraA.S., EvansH.L., BenjaminR.S.: Malignant melanoma of soft parts (clear cell sarcoma).A study of 17 cases, with emphasis on prognostic factors. Cancer, 65: 367–374, 1990.
19.
StegerG.G., WrbaF., MaderR., SchlappackO., DittrichC., RainerH.: Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses.Eur. J. Cancer, 27: 254–256, 1991.
20.
SuitH.D., RussellW.O., MartinR.G.Sarcoma of soft tissue: clinical and histopathological parameters and response to treatment.Cancer, 35: 1478–1483, 1975.
21.
TaguchiT.: Clinical studies of recombinant interferon alpha-2b (Roferon A) in cancer patients.Cancer, 57: 1705–1708, 1986.
22.
TsuneyoshiM., EnjojiM., KuboT.: Clear cell sarcoma of tendons and aponeuroses.A comparative study of 13 cases with a provisional subgrouping into the melanotic and synovial types. Cancer, 42: 243–252, 1978.
23.
YokoyamaR., MukaiK., HirotaT., BeppuY., FukumaH.: Primary malignant melanoma (clear cell sarcoma) of bone: report of a case arising in the ulna.Cancer, 1996, 77: 2471–2475.
